Whalesbook
Manipal Hospitals Prepares for India's Largest Healthcare IPO
Manipal Hospitals is gearing up to launch what could be India's biggest healthcare Initial Public Offering (IPO), planning to file its Draft Red Herring Prospectus (DRHP) soon. The company aims to raise ₹10,500 to ₹11,000 crore. A primary goal is to pay down approximately ₹8,000 crore in debt, freeing up funds for its aggressive expansion plans. This IPO seeks to secure its position as the country's largest hospital chain by bed capacity, a title it recently took from Apollo Hospitals.
IPO Aims to Slash Debt and Fuel Growth
The upcoming IPO is a significant financial step for Manipal Hospitals. It intends to use the substantial funds raised to tackle around ₹8,000 crore in debt, accumulated from recent acquisitions and capital spending. For instance, in July 2025, the company secured nearly ₹5,300 crore in debt financing specifically to acquire Sahyadri Hospitals for about ₹5,900 crore. Managing this debt load is key to its rapid growth strategy while maintaining financial health. The company is targeting a valuation of roughly ₹1.2 lakh crore, a considerable increase from its valuation three years ago when Temasek Holdings took a majority stake.
Building India's Largest Hospital Network
Manipal Hospitals has quickly become India's largest hospital network by bed count, operating nearly 50 facilities with around 13,000 beds. It achieved this through a consistent strategy of acquiring existing hospitals. Key recent acquisitions include Sahyadri Hospitals (₹6,000–₹6,400 crore) and an 84% stake in AMRI Hospitals (roughly ₹2,400 crore), boosting its presence in eastern India. The company has also agreed to buy an 87% stake in Medica Synergie for an estimated ₹1,400 crore. These deals, along with new projects in Bengaluru and Mumbai, are expected to raise its bed capacity to about 15,000. This focus on scale aims to outgrow competitors like Apollo Hospitals.
Valuation and Market Interest
The IPO's target valuation of ₹1.2 lakh crore would make Manipal Hospitals a top player in India's healthcare market. This valuation reflects its larger footprint and market leadership, building on Temasek's investment. Investor interest in India's healthcare sector remains strong, with a large pipeline of healthcare IPOs expected. While India's IPO market saw record fundraising in the last fiscal year, early 2026 showed some caution, with moderating subscriptions and investor wariness about smaller stocks. The average P/E for the sector, seen with Apollo Hospitals, is around 34.4x, suggesting Manipal's valuation might be ambitious.
Challenges Ahead
Despite its rapid growth and market lead, Manipal Hospitals faces challenges. Its aggressive acquisition strategy brings risks of integration difficulties and operational complexities. While the company aims to reduce debt, leverage remains a key factor. As of fiscal year end 2025, consolidated adjusted net debt, including lease obligations, was ₹51.35 billion. Projected substantial spending over the next two to three years could keep net adjusted leverage above 3x through FY27. Competition is intense. Rivals like Apollo Hospitals trade at a P/E of about 59.00, Max Healthcare Institute at 71.79, and Fortis Healthcare at 64.03. To justify its high valuation, Manipal needs not only sustained growth but also better profits and efficient capital use. Investor enthusiasm for healthcare IPOs has cooled, with reports in late 2025 noting a sharp drop in sector IPO activity.
Path Forward
Manipal Hospitals' future success depends on its ability to smoothly integrate its expanded network, manage its debt effectively, and turn rapid growth into lasting profits. The planned increase to 15,000 beds shows a clear vision for dominating the growing Indian healthcare market. The outcome of this significant IPO will signal investor confidence in its strategy and long-term prospects in a dynamic industry.